![Lionel Ségard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lionel Ségard
Fondateur chez
QUANTUM GENOMICS
Profil
Lionel Ségard is the founder of Quantum Genomics SA, which was founded in 2005.
He is also the founder of INSERM Transfert Initiative SAS. Mr. Ségard's current job is Chairman at Eurobiobiz SAS since 1999 and Vice Chairman at Rugby Club Massy Essonne SA since 2013.
Mr. Ségard's former job was Chief Executive Officer at INSERM Transfert SA from 2000 to 2006.
He obtained his undergraduate degree from Université de Paris XI Paris Sud.
Postes actifs de Lionel Ségard
| Sociétés | Poste | Début |
|---|---|---|
| QUANTUM GENOMICS | Fondateur | 23/12/2005 |
Rugby Club Massy Essonne SA
 Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club | Directeur/Membre du Conseil | - |
Eurobiobiz SAS
 Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe | Président | 01/01/1999 |
Anciens postes connus de Lionel Ségard
| Sociétés | Poste | Fin |
|---|---|---|
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Directeur Général | - |
INSERM Transfert Initiative SAS
 INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund | Fondateur | - |
Formation de Lionel Ségard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Finance |
Université de Paris XI Paris Sud
 Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eurobiobiz SAS
Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe | Health Technology |
INSERM Transfert Initiative SAS
INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Rugby Club Massy Essonne SA
Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club | Consumer Services |
Quantum Genomics SA
 Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases | Health Technology |
